http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-1811848-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13a1bcab03975e718bdfd94895ff8999 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
| filingDate | 1991-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1993-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd74f69f466c046bf2e9a54e044767e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b28584fda2370562028c7145b8e4db0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81e1b5b1a69a7d2fdb3bd4283deac97b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95549fb630650b0fe00dbde69fe68dec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1117d234ee8151ee3fdd4d7fcf048031 |
| publicationDate | 1993-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-1811848-C |
| titleOfInvention | Method for treating patients suffering from severe shigellosis |
| abstract | The invention relates to medicine and relates to the pharmacotherapy of infectious diseases. The purpose of the invention is to reduce the duration of toxicosis and the duration of treatment. Patients are prescribed antibacterial therapy in accordance with the sensitivity of Shigella to antimicrobial agents, colloidal solutions (hemodez, reopoliglyukin, polydez), crystalloids (Trisol, Acesol, Chlosol, Quartasol) in an amount corresponding to the degree intoxications and indicators of hemodynamics, vitamins, glucocorticoids (prednisone, hydrocortisone) in mid-therapeutic doses. Additionally, splenin is prescribed at 4-6 ml per day intramuscularly and acetylcysteine intramuscularly in the form of a 10% solution 2-3 times a day or intravenously in the form of a 1-3% solution in a daily dosage of 50-80 mg / kg body weight and inside - enterodesis in the form of a 3-5% solution in an amount of 5 g 3 times a day. At the same time, the effectiveness of pharmacotherapy increases, the treatment time is reduced, which makes it advisable to use the proposed method in a hospital setting. 2 s.p., crystals, 1 tab. with |
| priorityDate | 1991-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.